On June 4-June 7, 2024, the 66th Annual Thomas L. Petty Aspen Lung Conference will convene at The Gant Conference Center in Aspen, Colorado. The theme of the conference will be “Pulmonary Fibrosis – Focusing on the Future”. The prevalence of fibrosis is increasing due to the aging population, advances in diagnostic tools and increased exposure to infectious agents and other environmental factors that impact pathogenesis. Understanding the effect of these factors on the clinical manifestation of different fibrosis pathologies and pursuing novel advances in lung regeneration after scarring will have a significant impact on lung health. The conference will highlight emerging concepts of shared relevance to the fields of fibrosis biology and fibrosis resolution and will address strategies to improve translation of scientific advances and therapeutic interventions to reduce the burden of fibrosis lung diseases.
With an emphasis on the integration of basic, translational and clinical approaches, the 66th Annual Aspen Lung Conference will focus on a central question: How can we use knowledge of cellular, molecular and genetic mechanisms that underlie repair of fibrotic lungs to develop effective approaches to treat pulmonary fibrosis? To address this central question, we have organized the program into a series of thematic sessions, preceded by an opening keynote address to frame the conference. The thematic sessions will focus on:
These diverse themes will be reconciled in a concluding Conference Summary presented by Patricia Sime, M.D., Professor of Medicine, Virginia Commonwealth University.
As with previous Aspen Lung Conferences, we will utilize the successful format of State of the Art presentations grouped with relevant, short presentations. Each presentation will have sufficient time for discussion to facilitate a lively exchange of new ideas and thoughts on the dynamic cellular and structural biology in lung fibrosis associated with disease progression and repair between scientific fields to identify emerging and shared interests that may lead to more efficient and productive research and advances in the treatment of pulmonary fibrosis.
We are particularly interested in attracting translational, basic or clinical research abstracts related to the broad topics above. Accordingly, we invite you and your colleagues to submit abstracts for consideration for a podium presentation and/or a poster at the conference (abstracts can be similar to those used for ATS). Please submit abstracts according to the instructions below.
On behalf of my Co-Chair, David Schwartz, M.D., we look forward to your participation in the Thomas L. Petty Aspen Lung Conference, 66th Annual Meeting and to a combination of outstanding science and great fun. We hope that you and your colleagues will be able to join us.
Elizabeth F. Redente, Ph.D. Chair, 66th Annual Meeting
Thomas L. Petty Aspen Lung Conference Associate Professor of Pediatrics Division of Cell Biology
National Jewish Health Denver, Colorado, USA
The deadline for abstract submission is February 14, 2024. All who submit abstracts are invited to attend the conference whether their abstract is accepted or not but must register if they plan to attend. Time limitations, however, do not allow all submitted abstracts to be presented. In the past, about one third of the submitted abstracts were accepted for podium presentations or poster sessions based on evaluation by a Selection Committee.
All investigators will be notified on or near March 31, 2024 about acceptance of their abstracts.
We will offer four Fellow Travel Awards to fellows whose abstracts have been accepted for podium presentations.
Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.
Thomas L. Petty Aspen Lung Conference
68th Annual Meeting
Pulmonary Vascular Disease
June 9-12, 2026